US · Healthcare

Sarepta Therapeutics Inc (SRPT)

Biotechnology

Sarepta Therapeutics Inc (SRPT) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for SRPT

P/E ratio

18.00

Sarepta Therapeutics Inc (SRPT) — FAQ

What is SRPT's P/E ratio?

The price-to-earnings (P/E) ratio for Sarepta Therapeutics Inc (SRPT) is 18.00 (data as of 2026-03-23).

Does Sarepta Therapeutics Inc pay a dividend?

Dividend yield is not available in the current snapshot for Sarepta Therapeutics Inc (SRPT). Check the MyAverix Finance app for the latest dividend data.

What sector is Sarepta Therapeutics Inc in?

Sarepta Therapeutics Inc (SRPT) is classified in the Healthcare sector (Biotechnology industry).

What exchange is SRPT listed on?

SRPT is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)